首页> 外文期刊>Online Journal of Public Health Informatics >Influenza laboratory testing and its application in timely Department of Defense biosurveillance
【24h】

Influenza laboratory testing and its application in timely Department of Defense biosurveillance

机译:流感实验室检测及其在国防部及时生物监测中的应用

获取原文
           

摘要

Objective To describe influenza laboratory testing and results in the Military Health System and how influenza laboratory results may be used in DoD Electronic Surveillance System for Early Notification of Community-based Epidemics (ESSENCE) Introduction Timely influenza data can help public health decision-makers identify influenza outbreaks and respond with preventative measures. DoD ESSENCE has the unique advantage of ingesting multiple data sources from the Military Health System (MHS), including outpatient, inpatient, and emergency department (ED) medical encounter diagnosis codes and laboratory-confirmed influenza data, to aid in influenza outbreak monitoring. The Influenza-like Illness (ILI) syndrome definition includes ICD-9 or ICD-10 codes that may increase the number of false positive alerts. Laboratory-confirmed influenza data provides an increased positive predictive value (PPV). The gold standard for influenza testing is molecular assays or viral culture. However, the tests may take 3-10 days to result. Rapid influenza diagnostic tests (RIDTs) have a lower sensitivity, but the timeliness of receiving a result improves to within 15 minutes. We evaluate the utility of RIDTs for routine ILI surveillance. Methods Administrative medical encounters for ILI and influenza laboratory-confirmed data were analyzed from the MHS from June 2013 – September 2017 (Figure 1). The medical encounters and laboratory data include outpatient, inpatient, and ED data. The ILI syndrome case definition is a medical encounter during the study period with an ICD-9 or ICD-10 codes in any diagnostic position (ICD-9 codes = 79.99, 382.9, 460, 461.9, 465.8, 465.9, 466.0, 486, 487.0, 487.1, 487.8, 488, 490, 780.6, or 786.2; ICD-10 codes = B97.89, H66.9, J00, J01.9, J06.9, J09, J09.X, J10, J10.0, J10.1, J10.2, J10.8, J11, J11.0, J11.1, J11.2, J11.8, J12.89, J12.9, J18, J20.9, J40, R05, R50.9). The ILI dataset was limited to care provided in the MHS as laboratory data is only available for direct care. We describe influenza laboratory testing practices in the MHS. We aggregated the ILI encounters and RIDT positive results into daily counts and generated a weekly Pearson’s correlation. Results Influenza tests are ordered throughout the year; the mean weekly percentage of ILI encounters in which an influenza laboratory test is ordered is 5.62%, with a range from 0.68% in the off season to 19.2% during peak influenza activity. The mean weekly percentage of positive influenza laboratory results among all ILI encounters is 0.82%, with a range from 0.01% to 5.73% (Figure 2). The percent of ILI encounters in which a test is ordered increases as the influenza season progresses. Influenza laboratory tests conducted in the MHS include RIDTs, PCR, culture, and DFA. Among all influenza tests ordered in the MHS, 66.0% were RIDTs, 22.7% were PCR, and 11.3% were viral culture. Often, a confirmatory test is ordered following a RIDT; 20% of RIDTs have follow-up tests. The mean timeliness of influenza test result data in the MHS was 11.26 days for viral culture, 2.94 days for PCR, and 0.11 days for RIDTs. The RIDT results were moderately correlated with ILI encounters for the entire year (mean weekly Pearson correlation coefficient rho=0.60, 95% CI: 0.55, 0.66, Figure 3). During the influenza season, the mean weekly Pearson correlation coefficient increases to rho=0.75, 95% CI: 0.70, 0.79. Conclusions The DoD has the unique advantage of access to the electronic health record and laboratory tests and results of all MHS beneficiaries. This analysis provides evidence for increased utilization of positive RIDTs in ESSENCE. The moderate correlation between the ILI syndrome and positive RIDTs may be associated with ICD-10 codes included in the ILI syndrome definition that contribute to false positive influenza cases. Ongoing research is focused on improving this ILI syndrome definition using ICD-10 codes. Rapid influenza diagnostic tests provide more timely results than other influenza test types. In conjunction with ILI medical encounter data, positive RIDT data provides a more complete and timely picture of the true burden of influenza on the MHS population for early warning of influenza outbreaks.
机译:目的描述军事卫生系统中的流感实验室检测和结果,以及如何在国防部电子监视系统中将流感实验室的结果用于社区流行病的早期通知(ESSENCE)简介及时的流感数据可以帮助公共卫生决策者识别流感爆发并采取预防措施。 DoD ESSENCE具有从军事卫生系统(MHS)提取多个数据源(包括门诊,住院和急诊室(ED)医疗遭遇诊断代码和实验室确认的流感数据)的独特优势,以帮助进行流感爆发监测。流感样疾病(ILI)综合征定义包括ICD-9或ICD-10代码,这些代码可能会增加误报的数量。实验室确认的流感数据可提高阳性预测值(PPV)。流感检测的金标准是分子测定或病毒培养。但是,测试可能需要3到10天才能完成。快速流感诊断测试(RIDT)的灵敏度较低,但是接收结果的及时性提高到了15分钟以内。我们评估了RIDT在常规ILI监测中的效用。方法从2013年6月至2017年9月,从MHS中分析ILI和流感实验室确认数据的行政医疗遭遇(图1)。医疗遭遇和实验室数据包括门诊,住院和ED数据。 ILI综合征病例定义是研究期间在医学上遇到的疾病,ICD-9或ICD-10代码处于任何诊断位置(ICD-9代码= 79.99、382.9、460、461.9、465.8、465.9、466.0、486、487.0 ,487.1、487.8、488、490、780.6或786.2; ICD-10代码= B97.89,H66.9,J00,J01.9,J06.9,J09,J09.X,J10,J10.0,J10 .1,J10.2,J10.8,J11,J11.0,J11.1,J11.2,J11.8,J12.89,J12.9,J18,J20.9,J40,R05,R50.9 )。 ILI数据集仅限于MHS中提供的护理,因为实验室数据仅可用于直接护理。我们在MHS中描述了流感实验室检测方法。我们将ILI遭遇和RIDT阳性结果汇总为每日计数,并生成了每周Pearson的相关性。结果全年订购流感检测。要求进行流感实验室检测的ILI接触的平均每周百分比为5.62%,范围从淡季的0.68%到高峰流感活动期间的19.2%。在所有ILI遭遇中,流感实验室化验阳性的平均每周百分比为0.82%,范围为0.01%至5.73%(图2)。随着流感季节的发展,需要进行测试的ILI遭遇百分率会增加。在MHS中进行的流感实验室测试包括RIDT,PCR,培养和DFA。在MHS订购的所有流感检测中,有66.0%是RIDT,22.7%是PCR,还有11.3%是病毒培养。通常,在RIDT之后需要进行确认性测试。 20%的RIDT有后续测试。在MHS中,流感病毒检测结果数据的平均及时性对于病毒培养是11.26天,对于PCR是2.94天,对于RIDT是0.11天。 RIDT结果与全年与ILI的遭遇有中等相关性(平均每周皮尔逊相关系数rho = 0.60,95%CI:0.55,0.66,图3)。在流感季节期间,每周平均皮尔逊相关系数增加到rho = 0.75,95%CI:0.70,0.79。结论国防部拥有访问电子健康记录和实验室测试以及所有MHS受益人的结果的独特优势。该分析为在ESSENCE中提高RIDT阳性利用率提供了证据。 ILI综合征和RIDT阳性之间的适度相关性可能与ILI综合征定义中包括的ICD-10代码有关,这些代码会导致假阳性流感病例。正在进行的研究集中在使用ICD-10代码改善这种ILI综合征定义上。快速流感诊断测试比其他流感测试类型提供更及时的结果。结合ILI医疗遭遇数据,RIDT阳性数据可以更完整,更及时地反映MHS人群的流感实际负担,以预警流感爆发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号